Astellas Pharma Europe Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011784
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Astellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a manufacturer and distributor of drug products. The company provides pharmaceutical drugs in the areas of oncology, transplantation, urology, anti-infective, pain management and dermatology. It also provides discovery and development of new medicines and produce wide range of established products. Astellas Pharma conducts research and development of drug products. The company operates through its drug discovery research center in Japan. It operates in Iceland, Ireland, South Africa, Portugal, Spain, Norway, Denmark, Belgium, the Netherlands, Germany, Switzerland, Hungary, Serbia, Italy, Turkey, France, Romania, Ukraine, Russia, the UAE and the UK, among others. Astellas Pharma is headquartered in Chertsey, the UK.

Astellas Pharma Europe Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
MediGene Completes Sale Of European Rights For Eligard To Astellas 10
Licensing Agreements 12
Optimer Pharma Enters Into Licensing Agreement With Astellas Pharma Europe For Fidaxomicin 12
Astellas Pharma Europe Expands Its Licensing Agreement With TOLMAR For Eligard 14
Asset Transactions 15
Grunenthal to Acquire Qutenza from Astellas Pharma Europe 15
Astellas Pharma Europe Ltd – Key Competitors 16
Astellas Pharma Europe Ltd – Key Employees 17
Astellas Pharma Europe Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma Europe Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Astellas Pharma Europe Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MediGene Completes Sale Of European Rights For Eligard To Astellas 10
Optimer Pharma Enters Into Licensing Agreement With Astellas Pharma Europe For Fidaxomicin 12
Astellas Pharma Europe Expands Its Licensing Agreement With TOLMAR For Eligard 14
Grunenthal to Acquire Qutenza from Astellas Pharma Europe 15
Astellas Pharma Europe Ltd, Key Competitors 16
Astellas Pharma Europe Ltd, Key Employees 17
Astellas Pharma Europe Ltd, Subsidiaries 18

★海外企業調査レポート[Astellas Pharma Europe Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sukhoi Company:企業の戦略・SWOT・財務分析
    Sukhoi Company - Strategy, SWOT and Corporate Finance Report Summary Sukhoi Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Patheon NV:戦略・SWOT・企業財務分析
    Patheon NV - Strategy, SWOT and Corporate Finance Report Summary Patheon NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nahar Capital & Financial Services Ltd. (NAHARCAP):企業財務及び戦略的SWOT分析
    Summary Nahar Capital & Financial Services Ltd. (NCFSL) is a non-banking finance company that provides investment and financial services. The company’s business activities comprise invests in shares, debentures, stock, bonds and securities, banks, mutual funds and any authority. It also invests in p …
  • Kumiai Chemical Industry Co., Ltd. (4996):企業財務及び戦略的SWOT分析
    Summary Kumiai Chemical Industry Co., Ltd. (Kumiai Chemical) is a chemicals manufacturing company that develops, manufactures and markets agricultural chemical products. The company's products include bactericides, herbicides, and insecticides. It offers various printed materials and other chemical …
  • Saudi Advanced Industries Company:企業概要及び財務分析
    Summary Strategic Defence Intelligence's "Saudi Advanced Industries Company - Company Profile and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financ …
  • Canadian Utilities Limited (CU):企業のM&A・提携動向(エネルギー分野)
    Summary Canadian Utilities Limited (CUL), an ATCO company, offers a wide range of services for companies engaged in utilities, energy, structures and logistics, and technologies. The company is engaged in electricity distribution and transmission, natural gas distribution, and natural gas transmissi …
  • Riviera Holdings Corp.:企業の戦略・SWOT・財務分析
    SummaryRiviera Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • SI-Bone, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary SI-Bone, Inc. (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company provides medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disrupt …
  • Viveve Medical, Inc. (formerly PLC Systems, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Viveve Medical, Inc. (formerly …
  • Singapore Technologies Kinetics, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Singapore Technologies Kinetics …
  • Seven Principles AG (T3T1):企業財務及び戦略的SWOT分析
    Summary Seven Principles AG (Seven Principles) is an information technology company that offers enterprise mobility services. The company’s services comprise IT consulting, process management, information management, cloud services, mobile solutions, SAP services, software solutions, and quality man …
  • Saras S.p.A. (SRS):企業のM&A・提携動向(発電分野)
    Summary Saras S.p.A. (Saras) is an energy company. It operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, as well as industri …
  • Hindusthan National Glass and Industries, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hindusthan National Glass and I …
  • Thales SA:企業の戦略・SWOT・財務分析
    Thales SA - Strategy, SWOT and Corporate Finance Report Summary Thales SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Sonatrach SPA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sonatrach SPA Mergers and Acqui …
  • Aposense Ltd. (APOS):企業の財務及び戦略的SWOT分析
    Summary Aposense Ltd. (Aposense), formerly NeuroSurvival Technologies Ltd, is a pharmaceutical company. It specializes in the formulation of proprietary conjugates to known approved therapies to improve their efficacy. Its Aposense Targeted Therapy (ATT) technology offers a unique platform for drug …
  • Fabchem China Limited (I54):企業概要、財務及び戦略的SWOT分析
    Summary Fabchem China Limited (Fabchem) is an investment holding company. The company produces and markets commercial explosive products. Its products include explosive devices, industrial fuse and initiating explosive devices, and industrial detonators. Fabchem’s explosive devices include boosters, …
  • Murphy Oil Corporation (MUR)(エネルギー分野):企業M&A動向
    Summary Murphy Oil Corporation (Murphy Oil) is an international upstream oil and gas company. The company explores for develops and produces oil and gas from its assets. it also holds refining and marketing operations in the United Kingdom that are held for sale. Murphy Oil classifies its exploratio …
  • CARBO Ceramics Inc. (CRR):企業の財務及び戦略的SWOT分析
    Summary CARBO Ceramics Inc. (CARBO Ceramics) is an oilfield services technology company which designs and builds optimized production enhancement solutions; engineered spill prevention and containment solutions; and environmental solutions. The company’s solutions focuses on increasing the productio …
  • Deutsche Bank Private Wealth Management (DBK):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Deutsche Bank Private Wealth Management" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆